A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...
The observation also marks a significant step toward a long-awaited universal cancer vaccine to boost the tumor-fighting ...
Synthetic and inexpensive to produce, aptamers are attractive alternatives to antibodies for biomedical diagnostics and therapeutics. When new aptamer binders are needed, for example, to detect a new ...
When Health and Human Services Secretary Robert F. Kennedy Jr. terminated $500 million in federal funding for mRNA vaccine research last week, claiming he had “reviewed the science,” his press release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback